NextCell publishes its Interim Report 2 2023/2024
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 2 for the period September 1, 2023 – Februari 29, 2024. The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Second quarter (2023-12-01 until 2024-02-29) ● Operating Income amounted to 2,405 (2,734) TSEK, of which Cellaviva amounted to 2,334 (2,107) TSEK.● Net Income amounted to 2,334 (